Bellicum Pharmaceuticals Inc
(London Stock Exchange, The : BLCM)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-1.23%194.031.2%$601.17m
GILDGilead Sciences, Inc.
-0.55%67.200.9%$500.57m
CELGCelgene Corporation
1.86%67.991.2%$485.49m
BIIBBiogen Inc.
-0.25%318.671.3%$464.97m
ILMNIllumina, Inc.
2.76%309.383.5%$397.26m
REGNRegeneron Pharmaceuticals, Inc.
1.99%344.002.6%$297.42m
VRTXVertex Pharmaceuticals Incorporated
1.25%161.751.9%$261.75m
AAgilent Technologies, Inc.
1.10%68.271.5%$218.34m
ALXNAlexion Pharmaceuticals, Inc.
2.13%119.312.0%$204.82m
SRPTSarepta Therapeutics, Inc.
0.47%117.7315.4%$146.69m
LGNDLigand Pharmaceuticals Incorporated
3.06%153.4223.1%$141.60m
EXASExact Sciences Corporation
3.14%66.7625.3%$134.61m
TSROTESARO, Inc.
-3.58%40.9614.4%$133.77m
NKTRNektar Therapeutics
-1.76%37.455.6%$119.83m
INCYIncyte Corporation
1.18%64.342.5%$114.29m

Company Profile

Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. It uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX.